Zobrazeno 1 - 10
of 195
pro vyhledávání: '"Fabian, Halleck"'
Autor:
Esteban Cortes Garcia, Alessia Giarraputo, Maud Racapé, Valentin Goutaudier, Cindy Ursule-Dufait, Pierre de la Grange, Lucie Adoux, Marc Raynaud, Clément Couderau, Fariza Mezine, Jessie Dagobert, Oriol Bestard, Francesc Moreso, Jean Villard, Fabian Halleck, Magali Giral, Sophie Brouard, Richard Danger, Pierre-Antoine Gourraud, Marion Rabant, Lionel Couzi, Moglie Le Quintrec, Nassim Kamar, Emmanuel Morelon, François Vrtovsnik, Jean-Luc Taupin, Renaud Snanoudj, Christophe Legendre, Dany Anglicheau, Klemens Budde, Carmen Lefaucheur, Alexandre Loupy, Olivier Aubert
Publikováno v:
Transplant International, Vol 37 (2024)
Recently, interest in transcriptomic assessment of kidney biopsies has been growing. This study investigates the use of NGS to identify gene expression changes and analyse the pathways involved in rejection. An Illumina bulk RNA sequencing on the pol
Externí odkaz:
https://doaj.org/article/9ecc3009d82f4404afee19ecf718e603
Autor:
Lutz Liefeldt, Johannes Waiser, Friederike Bachmann, Klemens Budde, Frank Friedersdorff, Fabian Halleck, Nils Lachmann, Robert Peters, Birgit Rudolph, Sinem Ünlü, Kaiyin Wu, Petra Glander
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 15, p 4305 (2024)
Background: The use of mammalian target of rapamycin inhibitors (mTORis) in kidney transplantation increases the risk of donor-specific human leukocyte antigen (HLA) antibody formation and rejection. Here, we investigated the long-term consequences o
Externí odkaz:
https://doaj.org/article/608266bf0310414fbb85ffbb44f15218
Autor:
François R. Girardin, Anna Nicolet, Oriol Bestard, Carmen Lefaucheur, Klemens Budde, Fabian Halleck, Sophie Brouard, Magali Giral, Pierre-Antoine Gourraud, Béatrice Horcholle, Jean Villard, Joachim Marti, Alexandre Loupy
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Introduction: Patient-Reported Outcomes (PRO) integrate a wide range of holistic dimensions that arenot captured within clinical outcomes. Particularly, from induction treatment to maintenance therapy, patient quality-of-life (QoL) of kidney transpla
Externí odkaz:
https://doaj.org/article/2e6caf2f781240f581c2326e49931e5f
Autor:
Salma Almutawakel, Fabian Halleck, Michael Dürr, Ulrike Grittner, Eva Schrezenmeier, Klemens Budde, Christian E. Althoff, Bernd Hamm, Ingolf Sack, Thomas Fischer, Stephan R. Marticorena Garcia
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 24, p 7547 (2023)
Hepatitis C virus (HCV) infection can lead to hepatic fibrosis. The advent of direct-acting antivirals (DAAs) has substantially improved sustained virological response (SVR) rates. In this context, kidney transplant recipients (KTRs) are of particula
Externí odkaz:
https://doaj.org/article/28a74d71144240caa7ea6b9e110a7800
Autor:
Ellen von Hoerschelmann, Johannes Münch, Linde Gao, Christian Lücht, Marcel G. Naik, Danilo Schmidt, Paul Pitzinger, Detlef Michel, Parthenopi Avaniadi, Eva Schrezenmeier, Mira Choi, Fabian Halleck, Klemens Budde
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 1, p 100 (2023)
(1) Background: CMV infections remain a problem after kidney transplantation, particularly if patients are refractory or resistant (r/r) to treatment with valganciclovir (VGCV) or ganciclovir (GCV). (2) Methods: In a single-center retrospective study
Externí odkaz:
https://doaj.org/article/ff715a1831e24bda91896c2027917703
Autor:
Michael Mikhailov, Klemens Budde, Fabian Halleck, Georgios Eleftheriadis, Marcel G. Naik, Eva Schrezenmeier, Friederike Bachmann, Mira Choi, Wiebke Duettmann, Ellen von Hoerschelmann, Nadine Koch, Lutz Liefeldt, Christian Lücht, Henriette Straub-Hohenbleicher, Johannes Waiser, Ulrike Weber, Bianca Zukunft, Bilgin Osmanodja
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 18, p 6103 (2023)
Kidney transplant recipients (KTRs) show higher morbidity and mortality from COVID-19 than the general population and have an impaired response to vaccination. We analyzed COVID-19 incidence and clinical outcomes in a single-center cohort of approxim
Externí odkaz:
https://doaj.org/article/c60dacef3cd549c49d352a68b9010325
Autor:
Roland Roller, Manuel Mayrdorfer, Wiebke Duettmann, Marcel G. Naik, Danilo Schmidt, Fabian Halleck, Patrik Hummel, Aljoscha Burchardt, Sebastian Möller, Peter Dabrock, Bilgin Osmanodja, Klemens Budde
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Patient care after kidney transplantation requires integration of complex information to make informed decisions on risk constellations. Many machine learning models have been developed for detecting patient outcomes in the past years. However, perfo
Externí odkaz:
https://doaj.org/article/2d2ae69cecd4409abaae3633b5294d5f
Autor:
Matthias Niemann, Yara Strehler, Nils Lachmann, Fabian Halleck, Klemens Budde, Gideon Hönger, Stefan Schaub, Benedict M. Matern, Eric Spierings
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Development of donor-specific human leukocyte antigen (HLA) antibodies (DSA) remains a major risk factor for graft loss following organ transplantation, where DSA are directed towards patches on the three-dimensional structure of the respective organ
Externí odkaz:
https://doaj.org/article/bbd636c2afcf480f920489f8af6db569
Autor:
Covadonga López del Moral, Kaiyin Wu, Marcel Naik, Bilgin Osmanodja, Aylin Akifova, Nils Lachmann, Diana Stauch, Sabine Hergovits, Mira Choi, Friederike Bachmann, Fabian Halleck, Eva Schrezenmeier, Danilo Schmidt, Klemens Budde
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundDe novo donor-specific HLA antibodies (dnDSA) are key factors in the diagnosis of antibody-mediated rejection (ABMR) and related to graft loss.MethodsThis retrospective study was designed to evaluate the natural course of dnDSA in graft fun
Externí odkaz:
https://doaj.org/article/71fe8385a0cc450eba43f66f76df149a
Autor:
Eva Wu, Nadine Koch, Friederike Bachmann, Marten Schulz, Evelyn Seelow, Ulrike Weber, Johannes Waiser, Fabian Halleck, Mirko Faber, Claus-Thomas Bock, Kai-Uwe Eckardt, Klemens Budde, Jörg Hofmann, Peter Nickel, Mira Choi
Publikováno v:
Pathogens, Vol 12, Iss 6, p 850 (2023)
There is a significant risk for ongoing and treatment-resistant courses of hepatitis E virus (HEV) infection in patients after solid organ transplantation. The aim of this study was to identify risk factors for the development of hepatitis E, includi
Externí odkaz:
https://doaj.org/article/28debcd230b64c11ae368d0fd33e1a08